Free UK shipping on all orders over £10

  • White Facebook Icon
  • White Twitter Icon
  • White YouTube Icon

References

Oxidative Stress

 prevent and repair damage done by the free radicals Oxidant-antioxidant system: role and significance in the human body. Irshad, M., Chaudhuri, PS. Department of Laboratory Medicine, New Delhi, India. Indian Journal of Experimental Biology 2002 Nov; 40(11):1233-9.. Oxidative damage and free radicals can contribute to serious health problems such as heart disease, macular degeneration, and diabetes Sunlight exposure, antioxidants, and age-related macular degeneration. Fletcher, AE., Bentham, GC., Agnew, M., et al. Department of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, England. Archives of Ophthalmology 2008 Oct; 126(10):1396-403. Role of oxidative stress in cardiovascular diseases. Dhalla, NS., Temsah, R., Netticadan, T. Institute of Cardiovascular Sciences, St Boniface General Hospital Research Centre and Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada. Journal of Hypertension 2000 June; 18(6):655-73. Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice.Johansen, JS., Harris, AK., Rychly, DJ., et al. University of Tromso, Tromso, Norway; Medical College of Georgia Vascular Biology Center, Augusta, Georgia, USA. Cardiovascular Diabetology 2005 Apr 29; 4(1):5..

But while many of today's popular health foods contain massive doses of antioxidants like vitamin C, loading the body with as many of the nutrients as possible isn't the cure-all some might hope; in fact, ingesting large quantities of antioxidants might actuallycontribute to some of the very categories of disease they're touted to prevent. One now-famous study — which was actually stopped early because of the risk to patient health — showed an association between taking beta-carotene supplements with an increased risk of lung cancer in smokers Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. Albanes, D., Heinonen, O., Taylor, P., et al. Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MA, USA. Journal of the National Cancer Institute 1996 Nov 6; 88(21):1560-70.. And other research has come up short in definitively linking antioxidant supplements to increased longevity or decreased risks of serious disease.

 

 

Resveratrol

  1.  Fujitaka K, et al Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment . Nutr Res. (2011)

  2.  Constant J Alcohol, ischemic heart disease, and the French paradox . Coron Artery Dis. (1997)

  3.  Lippi G, et al Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox" . Semin Thromb Hemost. (2010)

  4.  Mezzano D, et al Mediterranean diet, but not red wine, is associated with beneficial changes in primary haemostasis . Eur J Clin Nutr. (2003)

  5.  Mezzano D, et al Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors . Eur J Clin Nutr. (2001)

  6.  Zamora-Ros R, et al Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort . Br J Nutr. (2008)

  7.  Delmas D, et al Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer . Curr Drug Targets. (2006)

  8.  Timperio AM, et al Production of the phytoalexins trans-resveratrol and delta-viniferin in two economy-relevant grape cultivars upon infection with Botrytis cinerea in field conditions . Plant Physiol Biochem. (2012)

  9.  Liang Z, et al Characterization of polyphenolic metabolites in the seeds of Vitis germplasm . J Agric Food Chem. (2012)

  10.  Tříska J, et al Separation and identification of highly fluorescent compounds derived from trans-resveratrol in the leaves of Vitis vinifera infected by Plasmopara viticola . Molecules. (2012)

  11.  Concentration of the Phytoalexin Resveratrol in Wine

  12.  Huang X, Mazza G Simultaneous analysis of serotonin, melatonin, piceid and resveratrol in fruits using liquid chromatography tandem mass spectrometry . J Chromatogr A. (2011)

  13.  Diaz LE, et al Antioxidant, Antitubercular and Cytotoxic Activities of Piper imperiale . Molecules. (2012)

  14.  Poulose SM, et al Anthocyanin-rich açai (Euterpe oleracea Mart.) fruit pulp fractions attenuate inflammatory stress signaling in mouse brain BV-2 microglial cells .J Agric Food Chem. (2012)

  15.  Sobolev VS, Cole RJ trans-resveratrol content in commercial peanuts and peanut products . J Agric Food Chem. (1999)

  16.  Rius C, et al Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation . J Immunol. (2010)

  17.  Anisimova NY, et al Trans-, cis-, and dihydro-resveratrol: a comparative study . Chem Cent J. (2011)

  18.  Orallo F Comparative studies of the antioxidant effects of cis- and trans-resveratrol . Curr Med Chem. (2006)

  19.  Leiro J, et al Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes . J Leukoc Biol. (2004)

  20.  Fabbrocini G, et al Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study . Am J Clin Dermatol. (2011)

  21.  Belguendouz L, Fremont L, Linard A Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins . Biochem Pharmacol. (1997)

  22.  Lappalainen Z Sirtuins: a family of proteins with implications for human performance and exercise physiology . Res Sports Med. (2011)

  23.  Rahman S, Islam R Mammalian Sirt1: insights on its biological functions . Cell Commun Signal. (2011)

  24.  Milner J Cellular regulation of SIRT1 . Curr Pharm Des. (2009)

  25.  Verdin E, et al Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling . Trends Biochem Sci. (2010)

  26.  Li X, Kazgan N Mammalian sirtuins and energy metabolism . Int J Biol Sci. (2011)

  27.  White AT, Schenk S NAD+/NADH and skeletal muscle mitochondrial adaptations to exercise . Am J Physiol Endocrinol Metab. (2012)

  28.  Kelly G A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1 . Altern Med Rev. (2010)

  29.  Kelly GS A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2 . Altern Med Rev. (2010)

  30.  Agarwal B, Baur JA Resveratrol and life extension . Ann N Y Acad Sci. (2011)

  31.  Howitz KT, et al Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan . Nature. (2003)

  32.  Kaeberlein M, et al Substrate-specific activation of sirtuins by resveratrol . J Biol Chem. (2005)

  33.  Pacholec M, et al SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1 . J Biol Chem. (2010)

  34.  Beher D, et al Resveratrol is not a direct activator of SIRT1 enzyme activity . Chem Biol Drug Des. (2009)

  35.  SIRT1 activation by small molecules - kinetic and biophysical evidence for direct interaction of enzyme and activator

  36.  Hawley SA, et al Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation . Cell Metab. (2010)

  37.  AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

  38.  Park CE, et al Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase . Exp Mol Med. (2007)

  39.  Resveratrol stimulates AMP kinase activity in neurons

  40.  Cantó C, et al AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity . Nature. (2009)

  41.  Price NL, et al SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function . Cell Metab. (2012)

  42.  Lan F, et al SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation . J Biol Chem. (2008)

  43.  Hou X, et al SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase . J Biol Chem. (2008)

  44.  Park SJ, et al Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases . Cell. (2012)

  45.  Feige JN, et al Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation . Cell Metab. (2008)

  46.  Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal Muscle

  47.  Gerhart-Hines Z, et al Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha . EMBO J. (2007)

  48.  Rodgers JT, et al Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 . Nature. (2005)

  49.  Jäger S, et al AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha . Proc Natl Acad Sci U S A. (2007)

  50.  Scarpulla RC Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network . Biochim Biophys Acta. (2011)

  51.  Walle T, et al High absorption but very low bioavailability of oral resveratrol in humans . Drug Metab Dispos. (2004)

  52.  Cottart CH, et al Resveratrol bioavailability and toxicity in humans . Mol Nutr Food Res. (2010)

  53.  Howells LM, et al Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics . Cancer Prev Res (Phila). (2011)

  54.  Almeida L, et al Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers . Mol Nutr Food Res. (2009)

  55.  Chaudhary A, et al Multiple-dose lorazepam kinetics: shuttling of lorazepam glucuronide between the circulation and the gut during day- and night-time dosing intervals in response to feeding . J Pharmacol Exp Ther. (1993)

  56.  Metabolism and Disposition of Resveratrol in Rats: Extent of Absorption, Glucuronidation, and Enterohepatic Recirculation Evidenced by a Linked-Rat Model

  57.  Ho KJ Circadian rhythmic hepatic biliary flow, constituents, concentrations and excretory rates in patients after cholecystectomy . Chronobiologia. (1994)

  58.  Vaz-da-Silva M, et al Effect of food on the pharmacokinetic profile of trans-resveratrol . Int J Clin Pharmacol Ther. (2008)

  59.  la Porte C, et al Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects . Clin Pharmacokinet. (2010)

  60.  De Santi C, et al Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum . Xenobiotica. (2000)

  61.  Soleas GJ, Yan J, Goldberg DM Measurement of trans-resveratrol, (+)-catechin, and quercetin in rat and human blood and urine by gas chromatography with mass selective detection . Methods Enzymol. (2001)

  62.  Ultrasensitive assay for three polyphenols (catechin, quercetin and resveratrol) and their conjugates in biological fluids utilizing gas chromatography with mass selective detection

  63.  Smoliga JM, Baur JA, Hausenblas HA Resveratrol and health--a comprehensive review of human clinical trials . Mol Nutr Food Res. (2011)

  64.  De Santi C, et al Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids . Xenobiotica. (2000)

  65.  Pacifici GM Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature . Int J Clin Pharmacol Ther. (2004)

  66.  Boocock DJ, et al Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent . Cancer Epidemiol Biomarkers Prev. (2007)

  67.  Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study

  68.  Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers

  69.  Brown VA, et al Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis . Cancer Res. (2010)

  70.  Goldberg DM, Yan J, Soleas GJ Absorption of three wine-related polyphenols in three different matrices by healthy subjects . Clin Biochem. (2003)

  71.  Gresele P, et al Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production . J Nutr. (2008)

  72.  Soleas GJ, Yan J, Goldberg DM Ultrasensitive assay for three polyphenols (catechin, quercetin and resveratrol) and their conjugates in biological fluids utilizing gas chromatography with mass selective detection . J Chromatogr B Biomed Sci Appl. (2001)

  73.  Wenzel E, Somoza V Metabolism and bioavailability of trans-resveratrol . Mol Nutr Food Res. (2005)

  74.  A Global Survey of Trans-Resveratrol Concentrations in Commercial Wines

  75.  Wu JM, Hsieh TC, Wang Z Cardioprotection by resveratrol: a review of effects/targets in cultured cells and animal tissues . Am J Cardiovasc Dis. (2011)

  76.  Khan MA, Muzammil S, Musarrat J Differential binding of tetracyclines with serum albumin and induced structural alterations in drug-bound protein . Int J Biol Macromol. (2002)

  77.  Jannin B, et al Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake . Biochem Pharmacol. (2004)

  78.  Belguendouz L, Frémont L, Gozzelino MT Interaction of transresveratrol with plasma lipoproteins . Biochem Pharmacol. (1998)

  79.  Curry S, Brick P, Franks NP Fatty acid binding to human serum albumin: new insights from crystallographic studies . Biochim Biophys Acta. (1999)

  80.  Lançon A, et al Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process . Biochem Biophys Res Commun. (2004)

  81.  Wang Q, et al Resveratrol protects against global cerebral ischemic injury in gerbils . Brain Res. (2002)

  82.  Bertelli A, et al Plasma and tissue resveratrol concentrations and pharmacological activity . Drugs Exp Clin Res. (1998)

  83.  Vitrac X, et al Distribution of (14C)-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration . Life Sci. (2003)

  84.  Camont L, et al Radical-induced oxidation of trans-resveratrol . Biochimie. (2012)

  85.  Bass TM, et al Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans . Mech Ageing Dev. (2007)

  86.  Wang C, et al The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogaster . Age (Dordr). (2011)

  87.  Bauer JH, et al Expression of dominant-negative Dmp53 in the adult fly brain inhibits insulin signaling . Proc Natl Acad Sci U S A. (2007)

  88.  Bauer JH, et al dSir2 and Dmp53 interact to mediate aspects of CR-dependent lifespan extension in D. melanogaster . Aging (Albany NY). (2009)

  89.  Antosh M, et al Comparative transcriptional pathway bioinformatic analysis of dietary restriction, Sir2, p53 and resveratrol life span extension in Drosophila . Cell Cycle. (2011)

  90.  Flatt T, Tu MP, Tatar M Hormonal pleiotropy and the juvenile hormone regulation of Drosophila development and life history . Bioessays. (2005)

  91.  Chandrashekara KT, Shakarad MN Aloe vera or resveratrol supplementation in larval diet delays adult aging in the fruit fly, Drosophila melanogaster . J Gerontol A Biol Sci Med Sci. (2011)

  92.  Frankel S, Ziafazeli T, Rogina B dSir2 and longevity in Drosophila . Exp Gerontol. (2011)

  93.  Labbé A, et al Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndrome . J Gerontol A Biol Sci Med Sci. (2011)

  94.  Miller RA, et al Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice . J Gerontol A Biol Sci Med Sci. (2011)

  95.  Pearson KJ, et al Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span . Cell Metab. (2008)

  96.  Barger JL, et al A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice . PLoS One. (2008)

  97.  Baur JA, et al Resveratrol improves health and survival of mice on a high-calorie diet . Nature. (2006)

  98.  Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation

  99.  Chang Y, Wang SJ Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by resveratrol . Neurochem Int. (2009)

  100.  Gao ZB, Chen XQ, Hu GY Inhibition of excitatory synaptic transmission by trans-resveratrol in rat hippocampus . Brain Res. (2006)

  101.  Li M, et al Resveratrol inhibits neuronal discharges in rat hippocampal CA1 area . Sheng Li Xue Bao. (2005)

  102.  Gozlan H, Ben-Ari Y NMDA receptor redox sites: are they targets for selective neuronal protection . Trends Pharmacol Sci. (1995)

  103.  Abele R, et al Disulfide bonding and cysteine accessibility in the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor subunit GluRD. Implications for redox modulation of glutamate receptors . J Biol Chem. (1998)

  104.  Zhang LP, et al Effect of resveratrol on L-type calcium current in rat ventricular myocytes . Acta Pharmacol Sin. (2006)

  105.  Moldzio R, et al Protective effects of resveratrol on glutamate-induced damages in murine brain cultures . J Neural Transm. (2013)

  106.  Lee JG, et al Combined treatment with capsaicin and resveratrol enhances neuroprotection against glutamate-induced toxicity in mouse cerebral cortical neurons. Food Chem Toxicol. (2012)

  107.  Saleh MC, Connell BJ, Saleh TM Resveratrol preconditioning induces cellular stress proteins and is mediated via NMDA and estrogen receptors . Neuroscience. (2010)

  108.  Choi DW Glutamate neurotoxicity and diseases of the nervous system . Neuron. (1988)

  109.  Lin CH, Chen PS, Gean PW Glutamate preconditioning prevents neuronal death induced by combined oxygen-glucose deprivation in cultured cortical neurons .Eur J Pharmacol. (2008)

  110.  Wang Q, et al Resveratrol protects against neurotoxicity induced by kainic acid . Neurochem Res. (2004)

  111.  Gupta YK, Briyal S, Chaudhary G Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats . Pharmacol Biochem Behav. (2002)

  112.  Shetty AK Promise of resveratrol for easing status epilepticus and epilepsy . Pharmacol Ther. (2011)

  113.  Wu Z, et al Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats . Neurochem Res. (2009)

  114.  Friedman LK, et al Lack of resveratrol neuroprotection in developing rats treated with kainic acid . Neuroscience. (2013)

  115.  Friedman LK, et al Developmental regulation of glutamate and GABA(A) receptor gene expression in rat hippocampus following kainate-induced status epilepticus. Dev Neurosci. (1997)

  116.  Shen CH, et al Intrathecal etanercept partially restores morphine's antinociception in morphine-tolerant rats via attenuation of the glutamatergic transmission .Anesth Analg. (2011)

  117.  Shimoyama N, et al An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance . J Pharmacol Exp Ther. (2005)

  118.  Tsai RY, et al Resveratrol regulates N-methyl-D-aspartate receptor expression and suppresses neuroinflammation in morphine-tolerant rats . Anesth Analg. (2012)

  119.  Cousins SL, Stephenson FA Identification of N-methyl-D-aspartic acid (NMDA) receptor subtype-specific binding sites that mediate direct interactions with scaffold protein PSD-95 . J Biol Chem. (2012)

  120.  Magistretti PJ Neuron-glia metabolic coupling and plasticity . J Exp Biol. (2006)

  121.  Araque A Astrocytes process synaptic information . Neuron Glia Biol. (2008)

  122.  Araque A, Carmignoto G, Haydon PG Dynamic signaling between astrocytes and neurons . Annu Rev Physiol. (2001)

  123.  Araque A, et al Tripartite synapses: glia, the unacknowledged partner . Trends Neurosci. (1999)

  124.  Hertz L Glutamate, a neurotransmitter--and so much more. A synopsis of Wierzba III . Neurochem Int. (2006)

  125.  Matés JM, et al Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death . Int J Biochem Cell Biol. (2002)

  126.  McKenna MC The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain . J Neurosci Res. (2007)

  127.  Quincozes-Santos A, Gottfried C Resveratrol modulates astroglial functions: neuroprotective hypothesis . Ann N Y Acad Sci. (2011)

  128.  dos Santos AQ, et al Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells . Arch Biochem Biophys. (2006)

  129.  de Almeida LM, et al Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures . Cell Mol Neurobiol. (2007)

  130.  Bobermin LD, et al Resveratrol prevents ammonia toxicity in astroglial cells . PLoS One. (2012)

  131.  Felipo V, Butterworth RF Neurobiology of ammonia . Prog Neurobiol. (2002)

  132.  Leite MC, et al Ammonia-induced alteration in S100B secretion in astrocytes is not reverted by creatine addition . Brain Res Bull. (2006)

  133.  Lemberg A, Fernández MA Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress . Ann Hepatol. (2009)

  134.  Kwon KJ, et al Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase Pathways . J Clin Neurol. (2010)

  135.  Kwon KJ, et al Melatonin synergistically increases resveratrol-induced heme oxygenase-1 expression through the inhibition of ubiquitin-dependent proteasome pathway: a possible role in neuroprotection . J Pineal Res. (2011)

  136.  Porquet D, et al Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8 . Age (Dordr). (2012)

  137.  Kao CL, et al Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation . J Atheroscler Thromb. (2010)

  138.  Zou J, et al Effects of resveratrol on oxidative modification of human low density lipoprotein . Chin Med J (Engl). (2000)

  139.  Zou JG, et al Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoprotein . Biochem Mol Biol Int. (1999)

  140.  Wallerath T, et al Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase . Circulation. (2002)

  141.  Kleinert H, et al Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved . Hypertension. (1998)

  142.  Thum T, et al Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes . Diabetes. (2007)

  143.  Li H, Förstermann U Prevention of atherosclerosis by interference with the vascular nitric oxide system . Curr Pharm Des. (2009)

  144.  Förstermann U, Münzel T Endothelial nitric oxide synthase in vascular disease: from marvel to menace . Circulation. (2006)

  145.  Li H, et al Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats . J Am Coll Cardiol. (2006)

  146.  Spanier G, et al Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4) . J Physiol Pharmacol. (2009)

  147.  Xia N, et al Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice . J Pharmacol Exp Ther. (2010)

  148.  Leonard SS, et al Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses . Biochem Biophys Res Commun. (2003)

  149.  Orallo F, et al The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption . Mol Pharmacol. (2002)

  150.  Resveratrol Increases Nitric Oxide Synthase, Induces Accumulation of p53 and p21WAF1/CIP1, and Suppresses Cultured Bovine Pulmonary Artery EndothelialCell Proliferation by Perturbing Progression through S and G2

  151.  Different Mechanisms of Endothelial Dysfunction With Aging and Hypertension in Rat Aorta

  152.  Rush JW, Denniss SG, Graham DA Vascular nitric oxide and oxidative stress: determinants of endothelial adaptations to cardiovascular disease and to physical activity . Can J Appl Physiol. (2005)

  153.  Rush JW, et al Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats . Exp Biol Med (Maywood). (2007)

  154.  Mizutani K, et al Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats . J Nutr Sci Vitaminol (Tokyo). (2000)

  155.  Wang Z, et al Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts .Biochem Biophys Res Commun. (2006)

  156.  Dealcoholized Red Wine Decreases Systolic and Diastolic Blood Pressure and Increases Plasma Nitric Oxide

  157.  Hsieh TC, et al Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53 . Biochem Biophys Res Commun. (2005)

  158.  Wang Z, et al Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography . Biochem Biophys Res Commun. (2004)

  159.  Buryanovskyy L, et al Crystal structure of quinone reductase 2 in complex with resveratrol . Biochemistry. (2004)

  160.  de Gaetano G, et al Antithrombotic effect of polyphenols in experimental models: a mechanism of reduced vascular risk by moderate wine consumption . Ann N Y Acad Sci. (2002)

  161.  Timmers S, et al Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans . Cell Metab. (2011)

  162.  Brasnyó P, et al Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients . Br J Nutr. (2011)

  163.  Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance

  164.  Ku CR, et al Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic β-cell and the cleavage of poly (ADP-ribose) polymerase . Endocr J. (2012)

  165.  Zhang J, et al The protective effect of resveratrol on islet insulin secretion and morphology in mice on a high-fat diet . Diabetes Res Clin Pract. (2012)

  166.  Minakawa M, et al Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic β-cells .J Clin Biochem Nutr. (2011)

  167.  Marchal J, et al Effects of Chronic Calorie Restriction or Dietary Resveratrol Supplementation on Insulin Sensitivity Markers in a Primate, Microcebus murinus .PLoS One. (2012)

  168.  Burgess TA, et al Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle . Arch Surg. (2011)

  169.  Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ

  170.  Umek RM, Friedman AD, McKnight SL CCAAT-enhancer binding protein: a component of a differentiation switch . Science. (1991)

  171.  Rayalam S, et al Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes . Phytother Res. (2008)

  172.  Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes

  173.  Szkudelska K, Nogowski L, Szkudelski T Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes . J Steroid Biochem Mol Biol. (2009)

  174.  Baile CA, et al Effect of resveratrol on fat mobilization . Ann N Y Acad Sci. (2011)

  175.  Fischer-Posovszky P, et al Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner . Am J Clin Nutr. (2010)

  176.  SIRT3, a Mitochondrial Sirtuin Deacetylase, Regulates Mitochondrial Function and Thermogenesis in Brown Adipocytes

  177.  Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

  178.  AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol

  179.  Dolinsky VW, et al Improvements in Skeletal Muscle Strength and Cardiac Function Induced by Resveratrol Contribute to Enhanced Exercise Performance in Rats . J Physiol. (2012)

  180.  Tomasello B, et al Double-Face Activity of Resveratrol in Voluntary Runners: Assessment of DNA Damage by Comet Assay . J Med Food. (2012)

  181.  de la Lastra CA, Villegas I Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications . Biochem Soc Trans. (2007)

  182.  Liu M, Liu F Resveratrol inhibits mTOR signaling by targeting DEPTOR . Commun Integr Biol. (2011)

  183.  Liu M, et al Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR . J Biol Chem. (2010)

  184.  Rajapakse AG, et al Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol . PLoS One. (2011)

  185.  Ghosh HS, McBurney M, Robbins PD SIRT1 negatively regulates the mammalian target of rapamycin . PLoS One. (2010)

  186.  Schreiner CE, et al Resveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent manner .Cardiovasc Res. (2011)

  187.  Haider UG, et al Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells . Mol Pharmacol. (2002)

  188.  Drummond MJ, et al Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis . J Physiol. (2009)

  189.  Jackson JR, Ryan MJ, Alway SE Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice . J Gerontol A Biol Sci Med Sci. (2011)

  190.  Momken I, et al Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat . FASEB J. (2011)

  191.  Marzetti E, et al Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty - a mini-review . Gerontology. (2012)

  192.  Jian B, et al Resveratrol Improves Cardiac Contractility following Trauma-Hemorrhage by Modulating Sirt1 . Mol Med. (2012)

  193.  Resveratrol Blunts the Positive Effects of Exercise Training on Cardiovascular Health in Aged Men

  194.  Smoliga JM, Blanchard OL Recent data do not provide evidence that resveratrol causes 'mainly negative' or 'adverse' effects on exercise training in humans . J Physiol. (2013)

  195.  Gliemann L, et al Reply from Lasse Gliemann, Jakob Schmidt, Jesper Olesen, Rasmus Sjørup Biensø, Sebastian Louis Peronard, Simon Udsen Grandjean, Stefan Peter Mortensen, Michael Nyberg, Jens Bangsbo, Henriette Pilegaard and Ylva Hellsten . J Physiol. (2013)

  196.  Continued Postnatal Administration of Resveratrol Prevents Diet-Induced Metabolic Syndrome in Rat Offspring Born Growth Restricted

  197.  Lagouge M, et al Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha . Cell. (2006)

  198.  Scribbans TD1, et al Resveratrol supplementation does not augment performance adaptations or fibre-type-specific responses to high-intensity interval training in humans . Appl Physiol Nutr Metab. (2014)

  199.  Gomez-Cabrera MC1, et al Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance . Am J Clin Nutr. (2008)

  200.  Paulsen G1, et al Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trial . J Physiol. (2014)

  201.  Bäckesjö CM, et al Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells . Cells Tissues Organs. (2009)

  202.  Resveratrol Stimulates the Proliferation and Differentiation of Osteoblastic MC3T3-E1 Cells

  203.  Preventing bone loss & weight gain with combinations of Vitamin D & phytochemicals

  204.  Morita Y, et al Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary . Reprod Biol Endocrinol. (2012)

  205.  Chen YC, et al Effects of genistein, resveratrol, and quercetin on steroidogenesis and proliferation of MA-10 mouse Leydig tumor cells . J Endocrinol. (2007)

  206.  Wang Y, et al The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells . Toxicol Sci. (2006)

  207.  Wang Y, Leung LK Pharmacological concentration of resveratrol suppresses aromatase in JEG-3 cells . Toxicol Lett. (2007)

  208.  Canistro D, et al Alteration of xenobiotic metabolizing enzymes by resveratrol in liver and lung of CD1 mice . Food Chem Toxicol. (2009)

  209.  Delmas D, et al Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines . Oncol Rep. (2000)

  210.  Sun ZJ, et al Anti-hepatoma activity of resveratrol in vitro . World J Gastroenterol. (2002)

  211.  Resveratrol Decreases Noise-Induced Cyclooxygenase-2 Expression in the Rat Cochlea

  212.  Leone S, et al Resveratrol induces DNA double-strand breaks through human topoisomerase II interaction . Cancer Lett. (2010)

  213.  De Salvia R, et al Resveratrol affects in a different way primary versus fixed DNA damage induced by H(2)O(2) in mammalian cells in vitro . Toxicol Lett. (2002)

  214.  Fukuhara K, Miyata N Resveratrol as a new type of DNA-cleaving agent . Bioorg Med Chem Lett. (1998)

  215.  Transient Transfection of a Wild-Type p53 Gene Triggers Resveratrol-Induced Apoptosis in Cancer Cells

  216.  Delmas D, et al Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells . J Biol Chem. (2003)

  217.  Pervaiz S Resveratrol--from the bottle to the bedside . Leuk Lymphoma. (2001)

  218.  Wenzel E, et al Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats . Mol Nutr Food Res. (2005)

  219.  Resveratrol: A Review of Pre-clinical Studies for Human Cancer Prevention

  220.  Gao X, et al Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes . J Nutr. (2002)

  221.  Oncogenic Activation of NF-κB

  222.  Kucharczak J, et al To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis . Oncogene. (2003)

  223.  Csaki C, Mobasheri A, Shakibaei M Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis . Arthritis Res Ther. (2009)

  224.  Benitez DA, et al Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells . Prostate. (2009)

  225.  Park ES, et al Pterostilbene, a natural dimethylated analog of resveratrol, inhibits rat aortic vascular smooth muscle cell proliferation by blocking Akt-dependent pathway . Vascul Pharmacol. (2010)

  226.  Bai Y, et al Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo . Cancer Sci. (2010)

  227.  Parekh P, et al Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells . Exp Toxicol Pathol. (2011)

  228.  Hope C, et al Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention . Mol Nutr Food Res. (2008)

  229.  Bishayee A, Dhir N Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis . Chem Biol Interact. (2009)

  230.  Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol

  231.  Wang Y, Ye L, Leung LK A positive feedback pathway of estrogen biosynthesis in breast cancer cells is contained by resveratrol . Toxicology. (2008)

  232.  Resveratrol Potentiates Genistein's Antiadipogenic and Proapoptotic Effects in 3T3-L1 Adipocytes

  233.  Kleinedler JJ, et al Synergistic effect of resveratrol and quercetin released from drug-eluting polymer coatings for endovascular devices . J Biomed Mater Res B Appl Biomater. (2011)

  234.  Yang JY, et al Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin . Life Sci. (2008)

  235.  Park HJ, et al Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes . J Med Food. (2008)

  236.  Rayalam S, Della-Fera MA, Baile CA Synergism between resveratrol and other phytochemicals: implications for obesity and osteoporosis . Mol Nutr Food Res. (2011)

  237.  Bruckbauer A, Zemel MB Effects of dairy consumption on SIRT1 and mitochondrial biogenesis in adipocytes and muscle cells . Nutr Metab (Lond). (2011)

  238.  Bruckbauer A, et al Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice . Nutr Metab (Lond). (2012)

  239.  Raj MH, et al Synergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cells . Gynecol Oncol. (2008)

  240.  Trusov NV, et al Effects of combined treatment with resveratrol and indole-3-carbinol . Bull Exp Biol Med. (2010)

  241.  Malhotra A, Nair P, Dhawan DK Curcumin and resveratrol synergistically stimulate p21 and regulate cox-2 by maintaining adequate zinc levels during lung carcinogenesis . Eur J Cancer Prev. (2011)

  242.  Walaszek Z Potential use of D-glucaric acid derivatives in cancer prevention . Cancer Lett. (1990)

  243.  Heerdt AS, Young CW, Borgen PI Calcium glucarate as a chemopreventive agent in breast cancer . Isr J Med Sci. (1995)

  244.  Olas B, Saluk-Juszczak J, Wachowicz B D-glucaro 1,4-lactone and resveratrol as antioxidants in blood platelets . Cell Biol Toxicol. (2008)

  245.  Kowalczyk MC, et al Synergistic effects of combined phytochemicals and skin cancer prevention in SENCAR mice . Cancer Prev Res (Phila). (2010)

  246.  Vetvicka V, et al Glucan and resveratrol complex--possible synergistic effects on immune system . Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. (2007)

  247.  Cristòfol R, et al Neurons from senescence-accelerated SAMP8 mice are protected against frailty by the sirtuin 1 promoting agents melatonin and resveratrol . J Pineal Res. (2012)

  248.  Lamont KT, et al Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection . J Pineal Res. (2011)

  249.  Kisková T, et al A combination of resveratrol and melatonin exerts chemopreventive effects in N-methyl-N-nitrosourea-induced rat mammary carcinogenesis . Eur J Cancer Prev. (2012)

  250.  Radhakrishnan S, et al Resveratrol potentiates grape seed extract induced human colon cancer cell apoptosis . Front Biosci (Elite Ed). (2011)

  251.  Therapeutic potential of resveratrol: the in vivo evidence

  252.  Edwards JA, et al Safety of resveratrol with examples for high purity, trans-resveratrol, resVida(®) . Ann N Y Acad Sci. (2011)

  253.  Johnson WD, et al Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity . Food Chem Toxicol. (2011)

  254.  Patel KR, et al Clinical trials of resveratrol . Ann N Y Acad Sci. (2011)

  255.  Davies M, Roulleau J Statement of retraction. Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkB . Free Radic Res. (2012)

  256.  Das S, et al Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and -independent pathways . J Pharmacol Exp Ther. (2005)

  257.  Gorbunov N, et al Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells . J Cell Mol Med. (2012)

  258.  Juhasz B, Mukherjee S, Das DK Hormetic response of resveratrol against cardioprotection . Exp Clin Cardiol. (2010)

  259.  Mukhopadhyay P, et al Restoration of altered microRNA expression in the ischemic heart with resveratrol . PLoS One. (2010)

  260.  Mukherjee S, Dudley JI, Das DK Dose-dependency of resveratrol in providing health benefits . Dose Response. (2010)

  261.  Das S, et al Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation . Am J Physiol Heart Circ Physiol. (2005)

  262.  Das S, Fraga CG, Das DK Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB . Free Radic Res. (2006)

  263.  Gurusamy N, et al Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium . J Cell Mol Med. (2010)

  264.  Bertelli A, et al Analgesic resveratrol . Antioxid Redox Signal. (2008)

  265.  Mukherjee S, et al Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol . Free Radic Biol Med. (2009)

  266.  Lekli I, Ray D, Das DK Longevity nutrients resveratrol, wines and grapes . Genes Nutr. (2010)

  267.  Lekli I, et al Co-ordinated autophagy with resveratrol and γ-tocotrienol confers synergetic cardioprotection . J Cell Mol Med. (2010)

  268.  Gurusamy N, et al Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway . Cardiovasc Res. (2010)

  269.  Zhu W, et al Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer . Nutr Cancer. (2012)

  270.  Magyar K, et al Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease . Clin Hemorheol Microcirc. (2012)

  271.  Kennedy DO, et al Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation . Am J Clin Nutr. (2010)

  272.  Crandall JP, et al Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance . J Gerontol A Biol Sci Med Sci. (2012)

 
 

Astragalus membranaceus

  1.  Zhang J, et al Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models . J Ethnopharmacol. (2009)

  2.  [No authors listed Astragalus membranaceus. Monograph . Altern Med Rev. (2003)

  3.  Wu F, Chen X {A review of pharmacological study on Astragalus membranaceus {Fisch.} Bge} . Zhong Yao Cai. (2004)

  4.  Kuo YH, et al Astragalus membranaceus flavonoids {AMF} ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming . J Ethnopharmacol. (2009)

  5.  Zhu J, et al In vitro intestinal absorption and first-pass intestinal and hepatic metabolism of cycloastragenol, a potent small molecule telomerase activator . Drug Metab Pharmacokinet. (2010)

  6.  ABSORPTION AND METABOLISM OF ASTRAGALI RADIX DECOCTION: IN SILICO, IN VITRO, AND A CASE STUDY IN VIVO

  7.  Kwon HJ, Park YD Determination of astragalin and astragaloside content in Radix Astragali using high-performance liquid chromatography coupled with pulsed amperometric detection . J Chromatogr A. (2012)

  8.  Chemical markers for the quality control of herbal medicines: an overview

  9.  Chemical and Genetic Assessment of Variability in Commercial Radix Astragali (Astragalus spp.) by Ion Trap LC-MS and Nuclear Ribosomal DNA Barcoding Sequence Analyses

  10.  Zhang LJ, et al New isoflavonoid glycosides and related constituents from astragali radix ( Astragalus membranaceus ) and their inhibitory activity on nitric oxide production . J Agric Food Chem. (2011)

  11.  Hirotani M, et al Cycloartane triterpene glycosides from the hairy root cultures of Astragalus membranaceus . Phytochemistry. (1994)

  12.  Chemical Constituents of Astragali Radix, the Root of Astragalus membranaceus

  13.  Xu DJ, et al Molecular weight and monosaccharide composition of Astragalus polysaccharides . Molecules. (2008)

  14.  Saito S, et al Astragalin from Cassia alata Induces DNA Adducts in Vitro and Repairable DNA Damage in the Yeast Saccharomyces cerevisiae . Int J Mol Sci. (2012)

  15.  Structural analysis and bioactivity of a polysaccharide from the roots of Astragalus membranaceus (Fisch) Bge. var. mongolicus (Bge.) Hsiao

  16.  Wang P, et al HDTIC-1 and HDTIC-2, two compounds extracted from Astragali Radix, delay replicative senescence of human diploid fibroblasts . Mech Ageing Dev. (2003)

  17.  Lin LZ, et al Liquid chromatography-electrospray ionization mass spectrometry study of the flavonoids of the roots of Astragalus mongholicus and A. membranaceus . J Chromatogr A. (2000)

  18.  Zhang X, et al Simultaneous quantification of three isoflavonoid glycosides in rabbit plasma after oral administration of Astragalus mongholicus extract by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry . Anal Chim Acta. (2007)

  19.  Isoflavans and a pterocarpan from Astragalus mongholicus

  20.  Xu F, et al Absorption and metabolism of Astragali radix decoction: in silico, in vitro, and a case study in vivo . Drug Metab Dispos. (2006)

  21.  Bedir E, et al Cycloartane triterpene glycosides from the roots of Astragalus brachypterus and Astragalus microcephalus . J Nat Prod. (1998)

  22.  Zhang BQ, et al Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine . Vascul Pharmacol. (2007)

  23.  Nagasawa H, et al Effects of gold banded lily (Lilium auratum Lindl) or Chinese milk vetch (Astragalus sinicus L) on spontaneous mammary tumourigenesis in SHN mice . Anticancer Res. (2001)

  24.  Ohkawara S, et al Astrapterocarpan isolated from Astragalus membranaceus inhibits proliferation of vascular smooth muscle cells . Eur J Pharmacol. (2005)

  25.  Characterisation of a novel monomeric lectin (AML) from Astragalus membranaceus with anti-proliferative activity

  26.  Gu Y, et al Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali . Basic Clin Pharmacol Toxicol. (2004)

  27.  Yang WJ, et al Synergistic antioxidant activities of eight traditional Chinese herb pairs . Biol Pharm Bull. (2009)

  28.  Harley CB, et al A natural product telomerase activator as part of a health maintenance program . Rejuvenation Res. (2011)

  29.  Patent: Compositions and methods for increasing telomerase activity

  30.  de Jesus BB, et al The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence .Aging Cell. (2011)

  31.  Fauce SR, et al Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes . J Immunol. (2008)

  32.  Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes

  33.  Direct activation of telomerase by GH via phosphatidylinositol 3′-kinase

  34.  Kang SS, et al Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit . J Biol Chem. (1999)

  35.  Astragaloside IV Structure: Molecular Formula

  36.  Huang CR, et al Absorption enhancement study of astragaloside IV based on its transport mechanism in caco-2 cells . Eur J Drug Metab Pharmacokinet. (2006)

  37.  Zheng KY, et al The membrane permeability of Astragali Radix-derived formononetin and calycosin is increased by Angelicae Sinensis Radix in Caco-2 cells: A synergistic action of an ancient herbal decoction Danggui Buxue Tang . J Pharm Biomed Anal. (2012)

  38.  Zhang W, et al Quantitative determination of Astragaloside IV, a natural product with cardioprotective activity, in plasma, urine and other biological samples by HPLC coupled with tandem mass spectrometry . J Chromatogr B Analyt Technol Biomed Life Sci. (2005)

  39.  Zhang WD, et al Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs . Life Sci. (2006)

  40.  Pao LH, et al Herb-drug interaction of 50 Chinese herbal medicines on CYP3A4 activity in vitro and in vivo . Am J Chin Med. (2012)

  41.  Davies B, Morris T Physiological parameters in laboratory animals and humans . Pharm Res. (1993)

  42.  Mao XQ, et al Hypoglycemic effect of polysaccharide enriched extract of Astragalus membranaceus in diet induced insulin resistant C57BL/6J mice and its potential mechanism . Phytomedicine. (2009)

  43.  Paradies G, et al Age-dependent decline in the cytochrome c oxidase activity in rat heart mitochondria: role of cardiolipin . FEBS Lett. (1997)

  44.  Spiteller G Lipid peroxidation in aging and age-dependent diseases . Exp Gerontol. (2001)

  45.  Li XT, et al Mitochondrial Protection and Anti-aging Activity of Astragalus Polysaccharides and Their Potential Mechanism . Int J Mol Sci. (2012)

  46.  Luo Z, et al Astragalus membranaceus prevents daunorubicin-induced apoptosis of cultured neonatal cardiomyocytes: role of free radical effect of Astragalus membranaceus on daunorubicin cardiotoxicity . Phytother Res. (2009)

  47.  Mak DH, et al Dang-Gui Buxue Tang produces a more potent cardioprotective effect than its component herb extracts and enhances glutathione status in rat heart mitochondria and erythrocytes . Phytother Res. (2006)

  48.  Wang P, et al The two isomers of HDTIC compounds from Astragali Radix slow down telomere shortening rate via attenuating oxidative stress and increasing DNA repair ability in human fetal lung diploid fibroblast cells . DNA Cell Biol. (2010)

  49.  Wang PC, et al Two isomers of HDTIC isolated from Astragali Radix decrease the expression of p16 in 2BS cells . Chin Med J (Engl). (2008)

  50.  Haferkamp S, et al p16INK4a-induced senescence is disabled by melanoma-associated mutations . Aging Cell. (2008)

  51.  Beauséjour CM, et al Reversal of human cellular senescence: roles of the p53 and p16 pathways . EMBO J. (2003)

  52.  Li WZ, et al Protective effect of extract of Astragalus on learning and memory impairments and neurons' apoptosis induced by glucocorticoids in 12-month-old male mice . Anat Rec (Hoboken). (2011)

  53.  Park HJ, et al The Effects of Astragalus Membranaceus on Repeated Restraint Stress-induced Biochemical and Behavioral Responses . Korean J Physiol Pharmacol. (2009)

  54.  Effect of extract of astragalus on inflammatory factor and apoptosis after focal cerebral ischemia/reperfusion injury in rats

  55.  Huang XP, et al Astragalus extract alleviates nerve injury after cerebral ischemia by improving energy metabolism and inhibiting apoptosis . Biol Pharm Bull. (2012)

  56.  Qu YZ, et al Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the blood-brain barrier in rats . Eur J Pharmacol. (2009)

  57.  Luo Y, et al Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia . Neurosci Lett. (2004)

  58.  Chan WS, et al Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture . Neurochem Int. (2009)

  59.  Zhang WD, et al Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro . Planta Med. (2006)

  60.  Han XH, et al Astragaloside IV regulates expression of ATP-sensitive potassium channel subunits after ischemia-reperfusion in rat ventricular cardiomyocytes . J Tradit Chin Med. (2011)

  61.  Zhang WD, et al Astragaloside IV dilates aortic vessels from normal and spontaneously hypertensive rats through endothelium-dependent and endothelium-independent ways . Planta Med. (2006)

  62.  Zhang C, et al Mechanisms underlying vasorelaxant action of astragaloside IV in isolated rat aortic rings . Clin Exp Pharmacol Physiol. (2007)

  63.  Qiu LH, Xie XJ, Zhang BQ Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation . Biol Pharm Bull. (2010)

  64.  Zhang N, et al Astragaloside IV improves metabolic syndrome and endothelium dysfunction in fructose-fed rats . Molecules. (2011)

  65.  Chao M, et al Improving insulin resistance with traditional Chinese medicine in type 2 diabetic patients . Endocrine. (2009)

  66.  Bai F, et al Anti-hypertensive effects of shichimotsukokato in 5/6 nephrectomized Wistar rats mediated by the DDAH-ADMA-NO pathway . J Nat Med. (2012)

  67.  Li JX, et al Antihypertensive effect of total flavonoid fraction of Astragalus complanatus in hypertensive rats . Chin J Physiol. (2005)

  68.  Zheng KY, et al Flavonoids from Radix Astragali induce the expression of erythropoietin in cultured cells: a signaling mediated via the accumulation of hypoxia-inducible factor-1α . J Agric Food Chem. (2011)

  69.  Wang YF, et al Protective effect of Astragalus polysaccharides on ATP binding cassette transporter A1 in THP-1 derived foam cells exposed to tumor necrosis factor-alpha . Phytother Res. (2010)

  70.  Oram JF ATP-binding cassette transporter A1 and cholesterol trafficking . Curr Opin Lipidol. (2002)

  71.  Fujiwara Y, et al Triterpenoids isolated from Zizyphus jujuba inhibit foam cell formation in macrophages . J Agric Food Chem. (2011)

  72.  Yang QY, Lu S, Sun HR Clinical effect of Astragalus granule of different dosages on quality of life in patients with chronic heart failure . Chin J Integr Med. (2011)

  73.  Zhou ZL, Yu P, Lin D {Study on effect of Astragalus injection in treating congestive heart failure} . Zhongguo Zhong Xi Yi Jie He Za Zhi. (2001)

  74.  Liu H, et al {Effect of Shenqi Fuzheng injection (SFI) on immune function in patients with congestive heart failure} . Zhong Yao Cai. (2005)

  75.  Zhang JG, et al {Effect of Astragalus injection on plasma levels of apoptosis-related factors in aged patients with chronic heart failure} . Chin J Integr Med. (2005)

  76.  Liu ZG, Xiong ZM, Yu XY {Effect of astragalus injection on immune function in patients with congestive heart failure} . Zhongguo Zhong Xi Yi Jie He Za Zhi. (2003)

  77.  Lu S, et al Progress in the research of Radix Astragali in treating chronic heart failure: effective ingredients, dose-effect relationship and adverse reaction . Chin J Integr Med. (2011)

  78.  Fu S, et al Huangqi injection {a traditional Chinese patent medicine} for chronic heart failure: a systematic review . PLoS One. (2011)

  79.  Cheng Y, et al Astragalus polysaccharides lowers plasma cholesterol through mechanisms distinct from statins . PLoS One. (2011)

  80.  Ntanios FY, Jones PJ Effects of variable dietary sitostanol concentrations on plasma lipid profile and phytosterol metabolism in hamsters . Biochim Biophys Acta. (1998)

  81.  Wang YW, et al Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters . Lipids. (2003)

  82.  Vanstone CA, et al Unesterified plant sterols and stanols lower LDL-cholesterol concentrations equivalently in hypercholesterolemic persons . Am J Clin Nutr. (2002)

  83.  Acid treatment to improve psyllium functionality

  84.  Trautwein EA, Kunath-Rau A, Erbersdobler HF Increased fecal bile acid excretion and changes in the circulating bile acid pool are involved in the hypocholesterolemic and gallstone-preventive actions of psyllium in hamsters . J Nutr. (1999)

  85.  Astragalus Polysaccharide Improves Palmitate-Induced Insulin Resistance by Inhibiting PTP1B and NF-κB in C2C12 Myotubes

  86.  Wu Y, et al Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B . Acta Pharmacol Sin. (2005)

  87.  Zou F, et al Astragalus polysaccharides alleviates glucose toxicity and restores glucose homeostasis in diabetic states via activation of AMPK . Acta Pharmacol Sin. (2009)

  88.  Effects of APS on the Activity of AMPK of STZ-induced T2DM Rats

  89.  Liu M, et al Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle . J Ethnopharmacol. (2010)

  90.  Shen P, et al Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro . J Nutr. (2006)

  91.  Liu Y, et al Effects of Astragalus polysaccharides on proliferation and differentiation of 3T3-L1 preadipocytes . Zhong Xi Yi Jie He Xue Bao. (2007)

  92.  Wang SH, et al Effect of Astragalus polysaccharides and berberine on carbohydrate metabolism and cell differentiation in 3T3-L1 adipocytes . Zhongguo Zhong Xi Yi Jie He Za Zhi. (2004)

  93.  Xu ME, et al Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro . Acta Pharmacol Sin. (2006)

  94.  Xu A, et al Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice . Endocrinology. (2009)

  95.  Yamakawa J, et al A Kampo Medicine, Boi-ogi-to, Inhibits Obesity in Ovariectomized Rats . Evid Based Complement Alternat Med. (2010)

  96.  Cho WC, Leung KN In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus . J Ethnopharmacol. (2007)

  97.  Denzler KL, et al Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals . PLoS One. (2010)

  98.  Zhao LH, et al Characterization of polysaccharide from Astragalus radix as the macrophage stimulator . Cell Immunol. (2011)

  99.  Qin Q, et al Astragalus membranaceus Extract Activates Immune Response in Macrophages via Heparanase . Molecules. (2012)

  100.  Lee KY, Jeon YJ Macrophage activation by polysaccharide isolated from Astragalus membranaceus . Int Immunopharmacol. (2005)

  101.  Schepetkin IA, Quinn MT Botanical polysaccharides: macrophage immunomodulation and therapeutic potential . Int Immunopharmacol. (2006)

  102.  Lai PK, et al Isolation of Anti-inflammatory Fractions and Compounds from the Root of Astragalus membranaceus . Phytother Res. (2012)

  103.  He X, et al Inhibitory effect of Astragalus polysaccharides on lipopolysaccharide-induced TNF-a and IL-1β production in THP-1 cells . Molecules. (2012)

  104.  Yuan Y, Sun M, Li KS Astragalus mongholicus polysaccharide inhibits lipopolysaccharide-induced production of TNF-alpha and interleukin-8 . World J Gastroenterol. (2009)

  105.  Clement-Kruzel S, et al Immune modulation of macrophage pro-inflammatory response by goldenseal and Astragalus extracts . J Med Food. (2008)

  106.  Mao XF, et al Effects of beta-glucan obtained from the Chinese herb Astragalus membranaceus and lipopolysaccharide challenge on performance, immunological, adrenal, and somatotropic responses of weanling pigs . J Anim Sci. (2005)

  107.  Rajput ZI, et al Adjuvant effects of saponins on animal immune responses . J Zhejiang Univ Sci B. (2007)

  108.  Gao XH, et al Saponin fraction from Astragalus membranaceus roots protects mice against polymicrobial sepsis induced by cecal ligation and puncture by inhibiting inflammation and upregulating protein C pathway . J Nat Med. (2009)

  109.  You Y, et al Anti-atherosclerotic function of Astragali Radix extract: downregulation of adhesion molecules in vitro and in vivo . BMC Complement Altern Med. (2012)

  110.  Zhang WJ, et al Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression . Thromb Haemost. (2003)

  111.  Li S, Zhang Y, Zhao J Preparation and suppressive effect of astragalus polysaccharide in glomerulonephritis rats . Int Immunopharmacol. (2007)

  112.  Shao BM, et al A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb . Biochem Biophys Res Commun. (2004)

  113.  Du X, et al Astragalus polysaccharides enhance the humoral and cellular immune responses of hepatitis B surface antigen vaccination through inhibiting the expression of transforming growth factor β and the frequency of regulatory T cells . FEMS Immunol Med Microbiol. (2011)

  114.  Yin X, et al Enhancement of the innate immune response of bladder epithelial cells by Astragalus polysaccharides through upregulation of TLR4 expression .Biochem Biophys Res Commun. (2010)

  115.  Liu QY, et al Astragalus polysaccharides attenuate postburn sepsis via inhibiting negative immunoregulation of CD4+ CD25(high) T cells . PLoS One. (2011)

  116.  Qu LL, et al Astragalus membranaceus injection delayed allograft survival related with CD4+ CD25+ regulatory T cells . Transplant Proc. (2010)

  117.  Shao P, et al Regulation on maturation and function of dendritic cells by Astragalus mongholicus polysaccharides . Int Immunopharmacol. (2006)

  118.  Kim MY, et al Skeletal Growth and IGF Levels in Rats after HT042 Treatment . Phytother Res. (2012)

  119.  The development of functional food with plant extracts for enhancing growth rates

  120.  [Astragalus membranaceus promote expression of insulin-like growth factor 1 in rat model of olivo-cerebellar degeneration

  121.  Kim W, et al Astragalus membranaceus Ameliorates Reproductive Toxicity Induced by Cyclophosphamide in Male Mice . Phytother Res. (2012)

  122.  Krausz C, Sassone-Corsi P Genetic control of spermiogenesis: insights from the CREM gene and implications for human infertility . Reprod Biomed Online. (2005)

  123.  Jiang C, et al Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer . Cancer Res. (2006)

  124.  Kim IG, et al Screening of estrogenic and antiestrogenic activities from medicinal plants . Environ Toxicol Pharmacol. (2008)

  125.  Sheng B, et al The protective effects of the traditional Chinese herbs against renal damage induced by extracorporeal shock wave lithotripsy: a clinical study .Urol Res. (2011)

  126.  Ti YX, Pan ZX, Wu C Intervention of astragalus injection on the kidney injury after cardiopulmonary bypass of infants with congenital heart disease . Zhongguo Zhong Xi Yi Jie He Za Zhi. (2011)

  127.  Qu ZL, Dong H, Wang SD Effects of astragalus injection on renal function in patients after cardiac valve replacement with cardiopulmonary bypass . Zhongguo Zhong Xi Yi Jie He Za Zhi. (2009)

  128.  Su L, Mao JC, Gu JH Effect of intravenous drip infusion of cyclophosphamide with high-dose Astragalus injection in treating lupus nephritis . Zhong Xi Yi Jie He Xue Bao. (2007)

  129.  Zhao L, et al Integrated treatment of traditional Chinese medicine and western medicine for early- and intermediate-stage diabetic nephropathy . Nan Fang Yi Ke Da Xue Xue Bao. (2007)

  130.  Li SM, Yan JX, Yang L Effects of Astragalus injection on renal tubular function in patients with IgA nephropathy . Zhongguo Zhong Xi Yi Jie He Za Zhi. (2006)

  131.  Chen LP, Zhou QL, Yang JH Protective effects of astragali injection on tubular in patients with primary nephrotic syndrome . Zhong Nan Da Xue Xue Bao Yi Xue Ban. (2004)

  132.  Li M, et al Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy . J Ethnopharmacol. (2011)

  133.  Wojcikowski K, Johnson DW, Gobe G Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies . J Lab Clin Med. (2006)

  134.  Ahmed MS, et al Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus . Am J Kidney Dis. (2007)

  135.  A novel antioxidant agent, astragalosides, prevents shock wave-induced renal oxidative injury in rabbits

  136.  Zhang YW, Wu CY, Cheng JT Merit of Astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expressions of NF-kappaB and IkappaB in renal cortex of streptozotoxin-induced diabetic rats . J Ethnopharmacol. (2007)

  137.  Zhang YW, et al Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats . Horm Metab Res. (2006)

  138.  Ai P, et al Aqueous extract of Astragali Radix induces human natriuresis through enhancement of renal response to atrial natriuretic peptide . J Ethnopharmacol. (2008)

  139.  Cho WC, Leung KN In vitro and in vivo anti-tumor effects of Astragalus membranaceus . Cancer Lett. (2007)

  140.  Lee SJ, et al Oral administration of Astragalus membranaceus inhibits the development of DNFB-induced dermatitis in NC/Nga mice . Biol Pharm Bull. (2007)

  141.  Yang B, et al Protective effect of astragaloside IV against matrix metalloproteinase-1 expression in ultraviolet-irradiated human dermal fibroblasts . Arch Pharm Res. (2011)

  142.  Kim JH, et al Inhibitory effects of calycosin isolated from the root of Astragalus membranaceus on melanin biosynthesis . Biol Pharm Bull. (2009)

  143.  Chen X, et al The healing and anti-scar effects of astragaloside IV on the wound repair in vitro and in vivo . J Ethnopharmacol. (2012)

  144.  Peng LH, et al Topical Astragaloside IV-Releasing Hydrogel Improves Healing of Skin Wounds in Vivo . Biol Pharm Bull. (2012)

  145.  Shah M, et al Role of elevated plasma transforming growth factor-beta1 levels in wound healing . Am J Pathol. (1999)

  146.  Miller MC, Nanchahal J Advances in the modulation of cutaneous wound healing and scarring . BioDrugs. (2005)

  147.  Huh JE, et al Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways . Int Immunopharmacol. (2011)

  148.  Matkovic Z, et al Efficacy and safety of Astragalus membranaceus in the treatment of patients with seasonal allergic rhinitis . Phytother Res. (2010)

  149.  Cho JH, et al Myelophil, an extract mix of Astragali Radix and Salviae Radix, ameliorates chronic fatigue: a randomised, double-blind, controlled pilot study .Complement Ther Med. (2009)

  150.  Song ZH, et al Chemical and biological assessment of a traditional chinese herbal decoction prepared from Radix Astragali and Radix Angelicae Sinensis: orthogonal array design to optimize the extraction of chemical constituents . Planta Med. (2004)

  151.  Dong TT, et al Chemical and biological assessment of a chinese herbal decoction containing Radix Astragali and Radix Angelicae Sinensis: Determination of drug ratio in having optimized properties . J Agric Food Chem. (2006)

  152.  Ferulic acid: pharmaceutical functions, preparation and applications in foods

  153.  Zhao KJ, et al Molecular genetic and chemical assessment of radix Angelica (Danggui) in China . J Agric Food Chem. (2003)

  154.  Chang MS, et al Treatment with Astragali radix and Angelicae radix enhances erythropoietin gene expression in the cyclophosphamide-induced anemic rat . J Med Food. (2009)

  155.  Gao QT, et al A Chinese herbal decoction prepared from Radix Astragali and Radix Angelicae Sinensis induces the expression of erythropoietin in cultured Hep3B cells . Planta Med. (2008)

  156.  Yang M, et al An herbal decoction of Radix astragali and Radix angelicae sinensis promotes hematopoiesis and thrombopoiesis . J Ethnopharmacol. (2009)

  157.  Lei Y, Gao Q, Li YS Study on effects of Astragalus, Angelica and their combination on vascular endothelial cell proliferation in vitro . Zhongguo Zhong Xi Yi Jie He Za Zhi. (2003)

  158.  Tse HY, et al Angiogenic efficacy of simplified 2-herb formula (NF3) in zebrafish embryos in vivo and rat aortic ring in vitro . J Ethnopharmacol. (2012)

  159.  Tam JC, et al The in vivo and in vitro diabetic wound healing effects of a 2-herb formula and its mechanisms of action . J Ethnopharmacol. (2011)

  160.  Lau KM, et al Synergistic interaction between Astragali Radix and Rehmanniae Radix in a Chinese herbal formula to promote diabetic wound healing . J Ethnopharmacol. (2012)

  161.  Zhang Q, et al Transcriptional profiling of human skin fibroblast cell line Hs27 induced by herbal formula Astragali Radix and Rehmanniae Radix . J Ethnopharmacol. (2011)

  162.  Chan CM, et al Influence of an anti-diabetic foot ulcer formula and its component herbs on tissue and systemic glucose homeostasis . J Ethnopharmacol. (2007)

  163.  Or PM, et al Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms . Phytomedicine. (2012)

  164.  Huang X, et al Influence of astragalosides and Panax notoginseng saponins compatibility on MMP-9 and TIMP-1 after cerebral ischemia-reperfusion in mice .Zhongguo Zhong Yao Za Zhi. (2010)

  165.  Tan H, Huang XP, Deng CQ Effects of astragaloside and Panax notoginseng saponins combination on oxidative stress of cerebral ischemic reperfusion injury in mice . Zhong Xi Yi Jie He Xue Bao. (2010)

  166.  Xuejiang W, Ichikawa H, Konishi T Antioxidant potential of qizhu tang, a chinese herbal medicine, and the effect on cerebral oxidative damage after ischemia reperfusion in rats . Biol Pharm Bull. (2001)

  167.  Gao XH, et al Qi-Shao-Shuang-Gan, a combination of Astragalus membranaceus saponins with Paeonia lactiflora glycosides, ameliorates polymicrobial sepsis induced by cecal ligation and puncture in mice . Inflammation. (2011)

  168.  Yan F, et al Synergistic hepatoprotective effect of Schisandrae lignans with Astragalus polysaccharides on chronic liver injury in rats . Phytomedicine. (2009)

  169.  Liang XC, et al Therapeutic efficacy of Stephania tetrandra S. Moore for treatment of neovascularization of retinal capillary (retinopathy) in diabetes--in vitro study. Phytomedicine. (2002)

  170.  Tsutsumi T, et al Effects of oral administration of Stephania tetrandra S. Moore on neovascularization of retinal and choroidal capillaries of diabetes in rats .Phytother Res. (2008)

  171.  Tsutsumi T, et al Anti-hyperglycemic effect of fangchinoline isolated from Stephania tetrandra Radix in streptozotocin-diabetic mice . Biol Pharm Bull. (2003)

  172.  Ma W, et al Combined effects of fangchinoline from Stephania tetrandra Radix and formononetin and calycosin from Astragalus membranaceus Radix on hyperglycemia and hypoinsulinemia in streptozotocin-diabetic mice . Biol Pharm Bull. (2007)

  173.  Booth A, et al Oral dose-ranging developmental toxicity study of an herbal supplement (NT) and gallic acid in rats . Adv Ther. (2010)

  174.  Herbal composition and method for controlling body weight and composition

  175.  Effect of an herbal extract Number Ten (NT) on body weight in rats

  176.  Roberts AT, et al The safety and efficacy of a dietary herbal supplement and gallic acid for weight loss . J Med Food. (2007)

  177.  Chen HW, et al A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: a phase II double-blind, randomized placebo-controlled study . Clin Invest Med. (2012)

  178.  Haines CJ, et al A randomized, double-blind, placebo-controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women . Climacteric. (2008)

  179.  Zwickey H, et al The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD25 expression in humans: a pilot study . Phytother Res. (2007)

  180.  Chen CC, et al Chinese Herb Astragalus membranaceus Enhances Recovery of Hemorrhagic Stroke: Double-Blind, Placebo-Controlled, Randomized Study .Evid Based Complement Alternat Med. (2012)

 

NAD+, Nicotinamide Riboside , Pterostilbene

 
 
 
 

Advanced glycation end-product

  1.  "American Heart Association". Retrieved 5 May 2016.

  2.  Vistoli, G; De Maddis, D; Cipak, A; Zarkovic, N; Carini, M; Aldini, G (Aug 2013). "Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.". Free Radic Res. 47 (12): Suppl 1:3–27.doi:10.3109/10715762.2013.815348PMID 10946212.

  3. Glenn, J.; Stitt, A. (2009). "The role of advanced glycation end products in retinal ageing and disease". Biochimica et Biophysica Acta 1790 (10): 1109–1116.doi:10.1016/j.bbagen.2009.04.016PMID 19409449.

  4. Semba, R. D.; Ferrucci, L.; Sun, K.; Beck, J.; Dalal, M.; Varadhan, R.; Walston, J.; Guralnik, J. M.; Fried, L. P. (2009)."Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women". Aging clinical and experimental research 21(2):

  5. Semba, R.; Najjar, S.; Sun, K.; Lakatta, E.; Ferrucci, L. (2009)."Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults". American Journal of Hypertension 22 (1): 74–79.doi:10.1038/ajh.2008.320PMC 2637811.PMID 19023277.

  6. Yan, S. F.; D'Agati, V.; Schmidt, A. M.; Ramasamy, R. (2007). "Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging". Current molecular medicine 7(8): 699–710. doi:10.2174/156652407783220732.PMID 18331228.

  7.  ^ Brownlee, M (June 2005). "The pathobiology of diabetic complications: a unifying mechanism.". Diabetes 54 (6): 1615–25. doi:10.2337/diabetes.54.6.1615PMID 15919781.

  8. Pertyńska-Marczewska, M; Głowacka, E; Sobczak, M; Cypryk, K; Wilczyński, J (February 2009). "Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies.". American journal of reproductive immunology (New York, N.Y. : 1989) 61 (2): 175–82.doi:10.1111/j.1600-0897.2008.00679.xPMID 19143681.

  9.  Uribarri, J; Woodruff, S; Goodman, S; Cai, W; Chen, X; Pyzik, R; Yong, A; Striker, GE; Vlassara, H (June 2010). "Advanced glycation end products in foods and a practical guide to their reduction in the diet". Journal of the American Dietetic Association 110 (6): 911–16.e12.doi:10.1016/j.jada.2010.03.018PMC 3704564.PMID 20497781.

  10.  Prasad, Anand; Bekker, Peter; Tsimikas, Sotirios (2012-08-01). "Advanced glycation end products and diabetic cardiovascular disease". Cardiology in Review 20 (4): 177–183.doi:10.1097/CRD.0b013e318244e57cISSN 1538-4683.PMID 22314141.

  11. Di Marco, Elyse; Gray, Stephen P.; Jandeleit-Dahm, Karin (2013-01-01). "Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature".Frontiers in Endocrinology 4: 68.doi:10.3389/fendo.2013.00068ISSN 1664-2392.PMC 3672854PMID 23761786.

  12. Tan, KC; Chow, WS; Lam, JC; Lam, B; Bucala, R; Betteridge, J; Ip, MS (March 2006). "Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea.". Sleep 29 (3): 329–33. PMID 16553018.

  13. Srikanth, V; Maczurek, A; Phan, T; Steele, M; Westcott, B; Juskiw, D; Münch, G (May 2011). "Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.".Neurobiology of Aging 32 (5): 763–77.doi:10.1016/j.neurobiolaging.2009.04.016PMID 19464758.

  14. Simm, A; Wagner, J; Gursinsky, T; Nass, N; Friedrich, I; Schinzel, R; Czeslik, E; Silber, RE; Scheubel, RJ (July 2007). "Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery?". Experimental Gerontology 42 (7): 668–75. doi:10.1016/j.exger.2007.03.006.PMID 17482402.

  15. Zimmerman GA, Meistrell M 3rd, Bloom O, Cockroft KM, Bianchi M, Risucci D, Broome J, Farmer P, Cerami A, Vlassara H, et al. Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine. Proceedings of the National Academy of Sciences of the United States of America 1995 Apr 25;92(9):3744-8.

  16. Shaikh S, Nicholson LF. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation. J Neurosci Res. 2008 Jul;86(9):2071-82.

  17. Fuentealba D, Friguet B, Silva E. Advanced glycation endproducts induce photocrosslinking and oxidation of bovine lens proteins through type-I mechanism. Photochem Photobiol. 2009 Jan-Feb;85(1):185-94.

  18.  Gul A, Rahman MA, Hasnain SN. Role of fructose concentration on cataractogenesis in senile diabetic and non-diabetic patients. Graefes Arch Clin Exp Ophthalmol. 2009 Jun;247(6):809-14.

  19.  Haus, JM; Carrithers, JA; Trappe, SW; Trappe, TA (December 2007). "Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle.". Journal of applied physiology (Bethesda, Md. : 1985) 103 (6): 2068–76.doi:10.1152/japplphysiol.00670.2007PMID 17901242.

  20. Gugliucci A, Bendayan M (1996). "Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE peptides by renal proximal tubular cells". Diabetologia 39 (2): 149–60.doi:10.1007/BF00403957PMID 8635666.

  21. Yan HD, Li XZ, Xie JM, Li M (2007). "Effects of advanced glycation end products on renal fibrosis and oxidative stress in cultured NRK-49F cells". Chin. Med. J. 120 (9): 787–93.PMID 17531120.

  22. Ansari NA, Moinuddin, Ali R (2011). "Glycated lysine residues: a marker for non-enzymatic protein glycation in age-related diseases". DISEASE MARKERS 30 (6): 317–324.doi:10.3233/DMA-2011-0791PMC 3825483.PMID 21725160.

  23. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW (1995). "Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose". Biochemistry 34(11): 3702–9. doi:10.1021/bi00011a027PMID 7893666.

  24. Gugliucci A, Mehlhaff K, Kinugasa E, et al. (2007). "Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance". Clin. Chim. Acta 377 (1–2): 213–20. doi:10.1016/j.cca.2006.09.028PMID 17118352.

  25. Smedsrød B, Melkko J, Araki N, Sano H, Horiuchi S (1997)."Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells". Biochem. J. 322 (Pt 2): 567–73.PMC 1218227PMID 9065778.

  26.  Svistounov D, Smedsrød B (2004). "Hepatic clearance of advanced glycation end products (AGEs)—myth or truth?". J. Hepatol. 41 (6): 1038–40. doi:10.1016/j.jhep.2004.10.004.PMID 15582139.

  27.  Koschinsky, T; He, CJ; Mitsuhashi, T; Bucala, R; Liu, C; Buenting, C; Heitmann, K; Vlassara, H (Jun 10, 1997). "Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.".Proceedings of the National Academy of Sciences of the United States of America 94 (12): 6474–9.doi:10.1073/pnas.94.12.6474PMC 21074.PMID 9177242.

  28.  Hira Zafar (26 June 2012). "Inhibition of protein glycation and advanced glycation end products by ascorbic acid". African Journal of Biotechnology 11 (51). doi:10.5897/AJB11.4172.

  29.  Abdul, HM; Butterfield, DA (Feb 1, 2007). "Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.". Free radical biology & medicine 42 (3): 371–84.doi:10.1016/j.freeradbiomed.2006.11.006PMC 1808543.PMID 17210450.

  30.  Nandhini AT, Thirunavukkarasu V, Anuradha CV (August 2005)."Taurine prevents collagen abnormalities in high fructose-fed rats" (PDF). Indian J. Med. Res. 122 (2): 171–7.PMID 16177476.

  31. A. Gugliucci, "Sour Side of Sugar, A Glycation Web Page

  32.  "Aspirin inhibits the formation of... preview & related info". Mendeley. doi:10.1016/j.diabres.2006.12.024. Retrieved2013-11-13.

  33.  Bucala R, Cerami A (1992). "Advanced glycosylation: chemistry, biology, and implications for diabetes and aging". Adv. Pharmacol. Advances in Pharmacology 23: 1–34.doi:10.1016/S1054-3589(08)60961-8ISBN 9780120329236.PMID 1540533.

  34.  Guiotto A, Calderan A, Ruzza P, Borin G (2005). "Carnosine and carnosine-related antioxidants: a review". Current Medicinal Chemistry 12 (20): 2293–2315.doi:10.2174/0929867054864796PMID 16181134.

  35. "Novel inhibitors of advanced glycation endproducts".Arch. Biochem. Biophys. 419 (1): 63–79. 2013-03-25.doi:10.1016/j.abb.2003.08.009PMID 14568010.

  36.  Mizutani, K; Ikeda, K; Yamori, Y (Jul 21, 2000). "Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.". Biochemical and Biophysical Research Communications 274 (1): 61–7.doi:10.1006/bbrc.2000.3097PMID 10903896.

  37. Tang Y (May 2014). "Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling.". Lab Invest. 94 (5): 503–16.doi:10.1038/labinvest.2014.42PMID 24614199.

  38. "Academic Journals formerly published by NPG". Nature.com. Retrieved 2013-11-13.

  39.  Vasan, S; Zhang, X; Zhang, X; Kapurniotu, A; Bernhagen, J; Teichberg, S; Basgen, J; Wagle, D; Shih, D; Terlecky, I; Bucala, R; Cerami, A; Egan, J; Ulrich, P (Jul 18, 1996). "An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.".Nature 382 (6588): 275–8. doi:10.1038/382275a0.PMID 8717046.

  40. Monnier, V. M., Mustata, G. T., Biemel, K. L., Reihl, O., Lederer, M. O., Zhenyu, D. et al. (2005). "Cross-linking of the extracellular matrix by the maillard reaction in aging anddiabetes: An update on "a puzzle nearing resolution"". Annals of the New York Academy of Sciences 1043: 533–544.doi:10.1196/annals.1333.061PMID 16037276.

  41. Furber, J.D. (2006). "Extracellular glycation crosslinks: Prospects for removal". Rejuvenation Research (Elsevier Inc.) 9(2): 274–278. doi:10.1089/rej.2006.9.274PMID 16706655

Olive Leaf Extract

  1. Available at: http://www.tesisenred.net/bitstream/handle/10803/7208/tvk.pdf?sequence=1#page=30. Accessed March 8, 2013.

  2. Omar SH. Oleuropein in olive and its pharmacological effects. Sci Pharm. 2010;78(2):133-54.

  3. Wahle KW, Caruso D, Ochoa JJ, Quiles JL. Olive oil and modulation of cell signaling in disease prevention. Lipids.2004 Dec;39(12):1223-31.

  4. Waterman E, Lockwood B. Active components and clinical applications of olive oil. Altern Med Rev. 2007 Dec;12(4):331-42.

  5. Hamdi HK, Castellon R. Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochem Biophys Res Commun.2005 Sep 2;334(3):769-78.

  6. Ribeiro Rde A, Fiuza de Melo MM, De Barros F, Gomes C, Trolin G. Acute antihypertensive effect in conscious rats produced by some medicinal plants used in the state of Sao Paulo. J Ethnopharmacol.1986 Mar;15(3):261-9.

  7. Somova LI, Shode FO, Ramnanan P, Nadar A. Antihypertensive, antiatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. J Ethnopharmacol.2003 Feb;84(2-3):299-305.

  8. Khayyal MT, el-Ghazaly MA, Abdallah DM, Nassar NN, Okpanyi SN, Kreuter MH. Blood pressure lowering effect of an olive leaf extract (Olea europaea) in L-NAME induced hypertension in rats. Arzneimittelforschung.2002;52(11):797-802.

  9. Cherif S, Rahal N, Haouala M, et al. A clinical trial of a titrated Olea extract in the treatment of essential arterial hypertension. J Pharm Belg. 1996 Mar-Apr;51(2):69-71.

  10. Perrinjaquet-Moccetti T, Busjahn A, Schmidlin C, Schmidt A, Bradl B, Aydogan C. Food supplementation with an olive (Olea europaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother Res. 2008 Sep;22(9):1239-42.

  11. Susalit E, Agus N, Effendi I, et al. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril. Phytomedicine.2011 Feb 15;18(4):251-8.

  12. Available at: http://www.rxlist.com/capoten-drug.htm. Accessed March 11, 2013.

  13. Scheffler A, Rauwald HW, Kampa B, Mann U, Mohr FW, Dhein S. Olea europaea leaf extract exerts L-type Ca(2+) channel antagonistic effects. J Ethnopharmacol.2008 Nov 20;120(2):233-40.

  14. Gilani AH, Khan AU, Shah AJ, Connor J, Jabeen Q. Blood pressure lowering effect of olive is mediated through calcium channel blockade. Int J Food Sci Nutr.2005 Dec;56(8):613-20.

  15. Zare L, Esmaeili-Mahani S, Abbasnejad M, et al. Oleuropein, chief constituent of olive leaf extract, prevents the development of morphine antinociceptive tolerance through inhibition of morphine-induced L-type calcium channel overexpression. Phytother Res. 2012 Nov;26(11):1731-7.

  16. Visioli F, Bellosta S, Galli C. Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages. Life Sci. 1998;62(6):541-6.

  17. Rocha BS, Gago B, Barbosa RM, Laranjinha J. Dietary polyphenols generate nitric oxide from nitrite in the stomach and induce smooth muscle relaxation. Toxicology.2009 Nov 9;265(1-2):41-8.

  18. Palmieri D, Aliakbarian B, Casazza AA, et al. Effects of polyphenol extract from olive pomace on anoxia-induced endothelial dysfunction. Microvasc Res. 2012 May;83(3):281-9.

  19. Scoditti E, Calabriso N, Massaro M, et al. Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch Biochem Biophys. 2012 Nov 15;527(2):81-9.

  20. Dell’Agli M, Fagnani R, Galli GV, et al. Olive oil phenols modulate the expression of metalloproteinase 9 in THP-1 cells by acting on nuclear factor-kappaB signaling. J Agric Food Chem. 2010 Feb 24;58(4):2246-52.

  21. Jemai H, Bouaziz M, Fki I, El Feki A, Sayadi S. Hypolipidimic and antioxidant activities of oleuropein and its hydrolysis derivative-rich extracts from Chemlali olive leaves. Chem Biol Interact. 2008 Nov 25;176(2-3):88-98.

  22. Visioli F, Galli C. Oleuropein protects low density lipoprotein from oxidation. Life Sci. 1994;55(24):1965-71.

  23. Masella R, Vari R, D’Archivio M, et al. Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes. J Nutr.2004 Apr;134(4):785-91.

  24. Wang L, Geng C, Jiang L, et al. The anti-atherosclerotic effect of olive leaf extract is related to suppressed inflammatory response in rabbits with experimental atherosclerosis. Eur J Nutr. 2008 Aug;47(5):235-43.

  25. Impellizzeri D, Esposito E, Mazzon E, et al. The effects of oleuropein aglycone, an olive oil compound, in a mouse model of carrageenan-induced pleurisy. Clin Nutr. 2011 Aug;30(4):533-40.

  26. Carluccio MA, Siculella L, Ancora MA, et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol.2003 Apr 1;23(4):622-9.

  27. Turner R, Etienne N, Alonso MG, et al. Antioxidant and anti-atherogenic activities of olive oil phenolics. Int J Vitam Nutr Res. 2005 Jan;75(1):61-70.

  28. Dell’Agli M, Fagnani R, Mitro N, et al. Minor components of olive oil modulate proatherogenic adhesion molecules involved in endothelial activation. J Agric Food Chem. 2006 May 3;54(9):3259-64.

  29. Singh I, Mok M, Christensen AM, Turner AH, Hawley JA. The effects of polyphenols in olive leaves on platelet function. Nutr Metab Cardiovasc Dis. 2008 Feb;18(2):127-32.

  30. Zbidi H, Salido S, Altarejos J, et al. Olive tree wood phenolic compounds with human platelet antiaggregant properties. Blood Cells Mol Dis. 2009 May-Jun;42(3):279-85.

  31. Wainstein J, Ganz T, Boaz M, et al. Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. J Med Food. 2012 Jul;15(7):605-10.

  32. Gonzalez M, Zarzuelo A, Gamez MJ, Utrilla MP, Jimenez J, Osuna I. Hypoglycemic activity of olive leaf. Planta Med. 1992 Dec;58(6):513-5.

  33. Al-Azzawie HF, Alhamdani MS. Hypoglycemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits. Life Sci. 2006 Feb 16;78(12):1371-7.

  34. Jemai H, El Feki A, Sayadi S. Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats. J Agric Food Chem. 2009 Oct 14;57(19):8798-804.

  35. Eidi A, Eidi M, Darzi R. Antidiabetic effect of Olea europaea L. in normal and diabetic rats. Phytother Res. 2009 Mar;23(3):347-50.

  36. Poudyal H, Campbell F, Brown L. Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr. 2010 May;140(5):946-53.

  37. Simon D, Balkau B. Diabetes mellitus, hyperglycaemia and cancer. Diabetes Metab. 2010 Jun;36(3):182-91.

  38. Kontou N, Psaltopoulou T, Soupos N, et al. Metabolic syndrome and colorectal cancer: the protective role of Mediterranean diet--a case-control study. Angiology. 2012 Jul;63(5):390-6.

  39. Verberne L, Bach-Faig A, Buckland G, Serra-Majem L. Association between the Mediterranean diet and cancer risk: a review of observational studies. Nutr Cancer. 2010;62(7):860-70.

  40. Anter J, Fernandez-Bedmar Z, Villatoro-Pulido M, et al. A pilot study on the DNA-protective, cytotoxic, and apoptosis-inducing properties of olive-leaf extracts. Mutat Res. 2011 Aug 16;723(2):165-70.

  41. Corona G, Deiana M, Incani A, Vauzour D, Dessi MA, Spencer JP. Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects. Biochem Biophys Res Commun. 2007 Oct 26;362(3):606-11.

  42. Kimura Y, Sumiyoshi M. Olive leaf extract and its main component oleuropein prevent chronic ultraviolet B radiation-induced skin damage and carcinogenesis in hairless mice. J Nutr. 2009 Nov;139(11):2079-86.

  43. Sirianni R, Chimento A, De Luca A, et al. Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Mol Nutr Food Res. 2010 Jun;54(6):833-40.

  44. Menendez JA, Vazquez-Martin A, Oliveras-Ferraros C, et al. Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays. Int J Mol Med. 2008 Oct;22(4):433-9.

  45. Goulas V, Exarchou V, Troganis AN, et al. Phytochemicals in olive-leaf extracts and their antiproliferative activity against cancer and endothelial cells. Mol Nutr Food Res. 2009 May;53(5):600-8.

  46. Abdel-Hamid NM, El-Moselhy MA, El-Baz A. Hepatocyte lysosomal membrane stabilization by olive leaves against chemically induced hepatocellular neoplasia in rats. Int J Hepatol. 2011;2011:736581.

  47. Fares R, Bazzi S, Baydoun SE, Abdel-Massih RM. The antioxidant and anti-proliferative activity of the Lebanese Olea europaea extract. Plant Foods Hum Nutr. 2011 Mar;66(1):58-63.

  48. Grawish ME, Zyada MM, Zaher AR. Inhibition of 4-NQO-induced F433 rat tongue carcinogenesis by oleuropein-rich extract. Med Oncol. 2011 Dec;28(4):1163-8.

  49. Acquaviva R, Di Giacomo C, Sorrenti V, et al. Antiproliferative effect of oleuropein in prostate cell lines. Int J Oncol. 2012 Jul;41(1):31-8.

  50. Mohagheghi F, Bigdeli MR, Rasoulian B, Hashemi P, Pour MR. The neuroprotective effect of olive leaf extract is related to improved blood-brain barrier permeability and brain edema in rat with experimental focal cerebral ischemia. Phytomedicine. 2011 Jan 15;18(2-3):170-5.

  51. Pan J, Konstas AA, Bateman B, Ortolano GA, Pile-Spellman J. Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology. 2007 Feb;49(2):93-102. Epub 2006 Dec 20.

  52. Dekanski D, Selakovic V, Piperski V, Radulovic Z, Korenic A, Radenovic L. Protective effect of olive leaf extract on hippocampal injury induced by transient global cerebral ischemia and reperfusion in Mongolian gerbils. Phytomedicine.2011 Oct 15;18(13):1137-43.

  53. Khalatbary AR, Ahmadvand H. Neuroprotective effect of oleuropein following spinal cord injury in rats. Neurol Res. 2012 Jan;34(1):44-51.

  54. Bazoti FN, Bergquist J, Markides KE, Tsarbopoulos A. Noncovalent interaction between amyloid-beta-peptide (1-40) and oleuropein studied by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom. 2006 Apr;17(4):568-75.

  55. Daccache A, Lion C, Sibille N, et al. Oleuropein and derivatives from olives as Tau aggregation inhibitors. Neurochem Int. 2011 May;58(6):700-7.

  56. Rigacci S, Guidotti V, Bucciantini M, et al. Abeta(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. Curr Alzheimer Res. 2011 Dec;8(8):841-52.

  57. Flemmig J, Kuchta K, Arnhold J, Rauwald HW. Olea europaea leaf (Ph.Eur.) extract as well as several of its isolated phenolics inhibit the gout-related enzyme xanthine oxidase. Phytomedicine.2011 May 15;18(7):561-6.

  58. Impellizzeri D, Esposito E, Mazzon E, et al. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice. J Pharmacol Exp Ther.2011 Dec;339(3):859-69.

  59. Gong D, Geng C, Jiang L, Wang L, Yoshimura H, Zhong L. Mechanisms of olive leaf extract-ameliorated rat arthritis caused by kaolin and carrageenan. Phytother Res. 2012 Mar;26(3):397-402.

  60. Olive leaf. Monograph. Altern Med Rev. 2009 Mar;14(1):62-6.